Literature DB >> 1670763

Loss of heterozygosity on 6q, 16q, and 17p in human central nervous system primitive neuroectodermal tumors.

G A Thomas1, C Raffel.   

Abstract

The loss of genetic material from specific chromosomal locations in a given tumor type has been taken for evidence of the importance of tumor suppressor genes at these loci in the genesis of the tumor. The primitive neuroectodermal tumor of the central nervous system has such a loss on 17p in one-third of tumors. In this report, a detailed analysis of 17p loss in 23 tumors has been performed using 10 probes mapping to this region. In addition, an analysis for allelic deletion on chromosomes 6q, 16q, and 22q has been performed. Six of the 23 tumors showed loss of markers on 17p, and the area of common loss spanned 17p11.2 to 17pter. Five of 23 tumors showed loss of markers on 6q, and 3 showed loss on 16q. No tumor lost markers on 22q. Only one tumor showed loss at more than one location. These data suggest that primitive neuroectodermal tumors either are a heterogeneous group of tumors with more than one mechanism leading to a tumor or that more than one recessive oncogene may play a role in the genesis of these tumors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1670763

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  19 in total

1.  Molecular genetic studies of chromosome 11 and chromosome 22q DNA sequences in pediatric medulloblastomas.

Authors:  S Lescop; A Lellouch-Tubiana; G Vassal; C Besnard-Guerin
Journal:  J Neurooncol       Date:  1999-09       Impact factor: 4.130

Review 2.  Decreased expression of the intercellular adhesion molecule E-cadherin in prostate cancer: biological significance and clinical implications.

Authors:  L A Giroldi; J A Schalken
Journal:  Cancer Metastasis Rev       Date:  1993-03       Impact factor: 9.264

Review 3.  Invasion promoter versus invasion suppressor molecules: the paradigm of E-cadherin.

Authors:  M Mareel; M Bracke; F Van Roy
Journal:  Mol Biol Rep       Date:  1994-01       Impact factor: 2.316

Review 4.  Tumor suppressor genes and medulloblastoma.

Authors:  P H Cogen; J D McDonald
Journal:  J Neurooncol       Date:  1996-07       Impact factor: 4.130

Review 5.  Genetic alterations in glioma and medulloblastoma.

Authors:  B K Rasheed; S H Bigner
Journal:  Cancer Metastasis Rev       Date:  1991-12       Impact factor: 9.264

6.  Loss of constitutional heterozygosity in human astrocytomas.

Authors:  E Van de Kelft; K De Boulle; P Willems; J J Martin; P Selosse; B Van der Auwera
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

7.  Prognostic implications of chromosome 17p deletions in human medulloblastomas.

Authors:  S K Batra; R E McLendon; J S Koo; S Castelino-Prabhu; H E Fuchs; J P Krischer; H S Friedman; D D Bigner; S H Bigner
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

8.  Chromosome 17 abnormalities and lack of TP53 mutations in paediatric central nervous system tumours.

Authors:  C M Phelan; L Liu; M H Ruttledge; K Müntzning; P A Ridderheim; V P Collins
Journal:  Hum Genet       Date:  1995-12       Impact factor: 4.132

9.  Altered chromosome 6 in immortal human fibroblasts.

Authors:  K Hubbard-Smith; P Patsalis; J R Pardinas; K K Jha; A S Henderson; H L Ozer
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

10.  Molecular cloning and characterization of the human E-cadherin cDNA.

Authors:  M J Bussemakers; A van Bokhoven; S G Mees; R Kemler; J A Schalken
Journal:  Mol Biol Rep       Date:  1993-02       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.